2m 2m 2m 2m 2m 2m 2m
IGC Pharma (IGC)
NYSE
$0.25+$0.003 (+1.20%)
Price as of Aug 03, 2026 11:30 AM EDT- $26.0MMarket Cap
- -27.07%1-Year Change
- BiotechnologyIndustry
IGC Pharma (IGC)
$0.25+$0.003 (+1.20%)
IGC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.25 | ||
Change | -$0.0005 (-0.20%) | ||
Open | $0.26 | ||
High | $0.26 | ||
Low | $0.25 | ||
Previous Close | $0.25 | ||
Volume | 184,823 | ||
30-Day Average Volume | 374,297 | ||
1-Week Change | -5.68% | ||
1-Month Change | -8.46% | ||
1-Year Change | -27.07% | ||
3-Year Change | -24.55% | ||
5-Year Change | -85.93% | ||
Fundamentals | |||
Shares Outstanding | 104.4M | ||
Total Assets | $9.2M | ||
Market Cap | $26.0M | ||
Enterprise Value | $26.7M | ||
Period: QTR TTM FY | |||
Revenue | $317,000.00 | ||
Net Income | -$2.4M | ||
Free Cash Flow | -$1.2M | ||
EBIT | -$2.4M | ||
EBITDA | -$2.3M | ||
Net Working Capital | -$1.7M | ||
EPS | -$0.02 | ||
Enterprise Value/EBITDA | -11 | ||
Enterprise Value/Revenue | 84 | ||
P/B | 4 | ||
P/E | -12 | ||
PEG | 0 | ||
Price/Free Cash Flow | -21 | ||
Price/Operating Cash Flow | -21 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 04/19/2013 | ||
Earnings & Revenue